Abstract
Purpose: The aim of this study was to collect some data to validate a new scale to assess quality of life in lung cancer patients. Material and methods: Karnofsky Index and the 32 items that constitute the new instrument were assessed twice in 50 patients at stages III and IV: 1) At diagnosis just prior to begin the treatment, and 2) Three weeks later, while radiotherapy or chemotherapy treatments were yet being applied. Results: Factor analysis indicated that construct validity was satisfactory when items were reduced to 26 and clustered into two scales: 'functional and somatic scale' and 'psychosocial scale'. Both scales show a great reliability with Cronbach's alpha values higher than 0.80. Furthermore, criterion validity was also achieved since a high correlation between the Karnofsky Index and the 'functional and somatic scale' was observed. Conclusions: Results show that a good quality of life assessment can be obtained with this instrument using fewer items than other quality of life scales previously proposed.
| Original language | English |
|---|---|
| Pages (from-to) | 43-47 |
| Journal | Oncologia |
| Volume | 22 |
| Issue number | 3 |
| Publication status | Published - 1 Jan 1999 |
Keywords
- Assessment scale
- Lung cancer
- Quality of life
UN SDGs
This output contributes to the following Sustainable Development Goal(s)
